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Abstract. The microenvironment plays a fundamental role in 
carcinogenesis: Acidity and hypoxia are actively involved in this 
process. It is important to have in vitro models to study these 
mechanisms. The models that are most commonly referred to 
are the hypoxia chamber and the chemical induction [Cobalt (II) 
chloride]. It is not yet defined if these models are interchange-
able if the metabolic effect is the same, and if the results may 
be compared in these models. In the present study, the response 
to the effect of stress (hypoxia and acidity) in both models was 
evaluated. The results indicated that in the chemical model, the 
effect of hypoxia appeared in an early form at 6 h; whereas in 
the gas chamber the effect was slow and gradual and at 72 h 
there was an overexpression of erythropoietin (EPO), vascular 
endothelial growth factor (VEGF), carbonic anhydrase 9 (CA9) 
and hypoxia-inducible factor 1α (HIF1α). In addition to the 
genes analyzed by reverse transcription-quantitative poly-
merase chain reaction, the global expression analysis between 
both models revealed the 9 most affected genes in common. 
The present study additionally identified 3 potential genes 
(lysyl oxidase, ankyrin repeat domain 37, B-cell lymphoma 2 
interacting protein 3 like) previously identified in other studies, 
which may be considered as universal hypoxia genes along 
with HIF1α, EPO, VEGF, glucose transporter 1 (GLUT1), 
CA9, and LDH. To the best of the author's knowledge, this is 
the first time that both hypoxia models have been compared, 
and it was demonstrated that the effect of hypoxia induction 
was time sensitive in each model. These observations must be 
considered prior to selecting one of these models to identify 
selective hypoxia genes and their effects in cancer.
Introduction
Carcinogenesis is a process where potential alterations in 
oncogenes, proto-oncogenes, conductive genes and loss in 
tumor suppressor genes accumulate over time (1). Nevertheless, 
recent evidence has shown that changes in the metabolism 
of cancer cells might be an important factor responsible for 
neoplastic development. In the Hanahan and Weinberg (2) 
model, the authors propose that changes in metabolism and 
in cellular microenvironment are important modulators of a 
tumor's sustainment and progression. Changes in the tissue 
microenvironment including lack of nutrients, hypoxia, and 
acidosis activate intracellular signaling pathways leading to 
a selective cell physiologic program to sustain adaptation to 
a new microenvironment (3). Also, recent reports have been 
identified that acidity modulates significantly the generation 
of metastasis (4). However, there is still a lack of knowledge 
regarding the potential role of hypoxia and acidity on intracel-
lular transcriptomic phenotype.
During tumor development, the Hydrogen potential (pH) 
plays a potential role in the cellular division, the normal physi-
ological pH it is estimated at a range between of 7.1-7.2 (1). 
In this context, when tumor development occurs, this pH 
decreases; acidifying the microenvironment intra or extracel-
lularly, an acid microenvironment is favored, promoting a 
metastatic cell phenotype (5,6).
The normal atmospheric level of oxygen is 21%, 
(normoxia) (7), hypoxia occurs when there is a decrease in 
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oxygen tension below the critical level (1 to 2%) (8). Cellular 
hypoxia can occur in both physiological conditions and in 
different pathological conditions (9), and cells adapt immedi-
ately by inducing the hypoxia-inducible factor 1α (HIF1α) (10). 
The heterodimer HIF1α is composed of alpha and beta subunits. 
In normoxia conditions, HIF1α is constitutively expressed and 
degraded in a short period of time (11-14). Under a hypoxic 
scenario HIF1α regulates cellular homeostasis and systemic 
response by positive or negatively modulating the transcrip-
tional activation of selective genes, including those involved in 
energetic metabolism [glucose transporter 1 (GLUT1)], angio-
genesis [vascular endothelial growth factor (VEGF)], survival 
[erythropoietin (EPO)], pH maintaining [carbonic anhydrase 9 
(CA9)], cell death (CASP3 and CASP7), and others that facili-
tate oxygen supply or metabolic adaptation to hypoxia (11).
To address the effect of hypoxia on cell physiology, two 
classical cellular micro-environmental models have been 
carried out. The first model uses a hypoxia sealed chamber 
containing a mixture of gases where oxygen is at 1 to 2%. The 
second one uses a chemical agent, which is highly reactive 
with oxygen, for example, iron (deferoxamine); flavonoids, for 
example, quercetin; an inhibitor dependent of 2-oxoglutarate 
oxygenase; and transition metals, like cobalt (15). In fact, 
chemical induction with cobalt chloride (CoCl2) is the chem-
ical model most frequently used (16). The gas chamber and 
chemical models have been used interchangeably to evaluate 
the effect of hypoxia in different cellular environments. In 
general, we sought to identify networks of selective metabolic 
genes activated by both hypoxic models, cobalt chloride and 
chamber sealed by hypoxia, using microarray analysis. We 
hypothesized that chemical or cellular hypoxia could regulate 
time-dependent genes involved in cell viability, apoptosis, and 
cell proliferation.
Materials and methods
Cell culture and maintenance. We used the cell line Caco-2 
[adenocarcinoma colorectal; American Type Culture 
Collection (ATCC), Rockville, MD, USA] in all assays. 
Caco‑2 cell line was cultivated in Dulbecco's modified Eagle's 
medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., 
Waltham, MA, USA) supplemented with 10% fetal bovine 
serum, 1% penicillin-streptomycin, and was maintained at 
37˚C, with 5% CO2.
Gas chamber with induced hypoxia. A total of 150,000 Caco-2 
cells were seeded in each well, incubated for 24 h to allow their 
adhesion. The cultures were then placed into the gas chamber 
(Stemcell Technologies, Inc., Vancouver, BC, Canada). The 
chamber was closed and the gas mixture (1% O2, 5% CO2 
and 94% N2) was injected for 5 min (at a controlled pressure 
of 2 psi) to ensure equilibrium of the oxygen concentration 
in the cell medium, after which the chamber was sealed and 
finally placed in the incubator at 37˚C. Hypoxic treatment was 
maintained for 0, 3, 6, 24, 48 and 72 h.
Chemical hypoxia induction with cobalt chloride (CoCl2). 
For chemical hypoxia 150,000 Caco-2 cells were seeded in 
each well in the 6-well plates, incubated for 24 h to allow their 
adhesion and 100 µM CoCl2 (Sigma-Aldrich; Merck KGaA, 
Darmstadt, Germany) were added to the medium and were 
incubated for 0, 3, 6, 24, 48 and 72 h.
Acidosis assay. To simulate acidosis in our hypoxic model, 
the pH of the medium was determined by adding 25 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
or 25 mM 3-(N-morpholino) propanesulfonic acid (MOPS). 
Subsequently, the pH was measured using a SevenMulti stan-
dard potentiometer (Mettler Toledo, Greifensee, Switzerland), 
initially calibrated with reference buffer solutions (Hanna 
Instruments, Woonsocket, RI, USA), and was finally adjusted 
to 6.5, 6.7 or 6.9 with 1 M HCl.
Cell viability assay. Once pH and hypoxia conditions were 
selected, cell viability in the Caco-2 cell line was evalu-
ated, with the chemiluminescent assay using the Cell Titer 
Glo Luminescent kit (Promega Corporation, Madison, WI, 
USA). Caco-2 cells were seeded in 96-well plates in a density 
of 15,000 cells/well and were cultivated for 24 h at 37˚C in 
5% CO2 to allow their adhesion. They were then exposed 
to pH and hypoxia protocols during 0, 24, 48 and 72 h and 
the cell viability was measured. This method is based on the 
quantification of ATP in the culture, and the levels are directly 
proportional to the presence of metabolically active cells.
Apoptosis chemiluminescent assay. Apoptosis was determined 
using the Caspase-GloR 3/7 Assay Protocol kit (Promega 
Corporation). This assay measured caspase 3/7 activity and 
the luminescent signal that are directly proportional to the 
apoptosis level in the evaluated cells.
RNA extraction, reverse transcription‑quantitative poly‑
merase chain reaction (RT‑qPCR). To evaluate the effect of 
cellular stress by hypoxia and acidity on cell metabolism, we 
carried out a Real-Time mRNA expression analysis of a panel 
of genes involved in hypoxia-metabolism: HIF1α, EPO, 
GLUT1, VEGF, LDH and CA9 by qPCR and SYBR-Green 
using GAPDH as gene normalizer. We previously performed 
an assay for the selection of the endogenous gene (data not 
shown) was made by the comparison of GAPDH, GPI and 
EMC7 using a gene stability assay (17). Our results showed 
that compared to the GPI and EMC7 genes, the GAPDH 
gene was the most stable gene. Cultures were maintained 
under the hypoxia and acid protocols and total RNA was 
isolated using TRIzol reagent (Invitrogen; Thermo Fisher 
Scientific, Inc.), following instructions from the fabricators, 
followed by a treatment with DNAse (Qiagen, Inc., Valencia, 
CA, USA). RNA integrity and concentration was evaluated 
by spectrophotometry with Nanodrop 8000 (Thermo Fisher 
Scientific, Inc.).
cDNA was synthesized from 1 µg of total RNA using 
High-Capacity cDNA Reverse Transcription kit (Applied 
Biosystems; Thermo Fisher Scientific, Inc.), following the 
fabricator's instructions. The primers for the metabolic genes 
and the constitutive gene were designed in accordance with the 
sequences from the database Gen Bank (Table I). The real-time 
PCR thermal cycler LightCycler 480 (Roche Diagnostics, 
Indianapolis, IN, USA) and the reagent SYBR-Green I Master 
(Roche Diagnostics) were used. All the qPCR reactions were 
triplicated and three independent assays were carried out. 
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The expression analysis was carried out by the relative 2-ΔΔCq 
quantification method (18).
Microarrays analysis (expression profiles). The RNA, sample 
processing, microarray hybridization, and gene expression 
analysis were conducted using the GeneChip 3' IVT Express 
kit (Affymetrix; Thermo Fisher Scientific, Inc.). The hybrid-
ization mixture was prepared and applied to the GeneChip 
Human Genome U133 Plus 2.0 Array (Affymetrix; Thermo 
Fisher Scientific, Inc.), measuring >43,000 transcripts 
representing >20,000 human genes. Washing and scanning 
processes were realized in the Fluidics Station 400 and 
GeneChip Scanner 3000 7G, respectively, and preliminary 
data analysis was completed using Microarray Suite software 
version 5.0.0.032. Normalization was performed using robust 
microarray analysis and quantile normalization.
Statistical analysis. Data were compared using a two-way 
ANOVA (treatment and time) and Dunnet's test was performed 
to compare viability and apoptosis in all trials. The variables 
were previously normalized (Kolmogorov-Smirnov). The 
analysis was performed using SPSS software v20.0 (SPSS, 
Inc., Chicago, IL, USA). All graphs were done with GraphPad 
Prism v6.0 (GraphPad Software, Inc., La Jolla, CA, USA). All 
assays were performed in triplicate. Results are expressed as 
the mean ± standard deviation.
Results
Viability assays in chemical and sealed gas chamber hypoxia 
models. To determine the effect of hypoxia on cell viability, 
cells treated with CoCl2 or maintained in the gas chamber 
were quantified as described. When comparing viability 
based on time and treatment, a highly significant difference 
was found in time (F=15.396, P<0.01) and for the treatment 
(F=17.288, P<0.01). We found a significant decrease in cell 
viability in cells treated with CoCl2 at 48 h and 72 h compared 
to the control without chemical hypoxia (Fig. 1A). In contrast, 
hypoxia-induced in sealed gas chamber shows a substantial 
increase in cell viability at a similar time frame to chemical 
hypoxia, 48 and 72 h (Fig. 1B).
Apoptosis evaluation in chemical and sealed gas chamber 
hypoxia models. The caspase 3/7 activity ratio was measured 
to evaluate apoptosis in both hypoxia models. The results of 
apoptosis displayed significant changes between the control 
at time 72 h (F=964.923, P<0.01) and for the treatment of 
hypoxia chamber (F=1,154.081, P<0.01). It was observed 
that chemically induced hypoxia does not promote apoptotic 
activation when compared to the normoxia control in all the 
times (Fig. 1C). We did find that hypoxia induced by the gas 
chamber decreased apoptosis significantly at 72 h compared to 
the normal control (Fig. 1D). This data suggests that a hypoxic 
environment induced by gas chamber incubation may have a 
severe effect on oxygen depletion leading to cell death and 
does not favor proliferation.
Evaluation of the effect of pH and pH+ hypoxia on viability 
and apoptosis in both models of hypoxia. We evaluated 
the acidity effect in the chemical and sealed gas chamber 
hypoxia models by setting three pH values: 6.5, 6.7 and 6.9. 
An increase in cell viability was observed at 48 and 72 h 
when the cells were exposed to the most acidic pH (Ph 6.7 
and 6.9), compared against normoxia conditions (Fig. 2A 
and B). We also found that viability and apoptosis showed 
time-dependent significant changes (F=18.759, F=55.840, 
P<0.01), whereas at pH 6.5 there was a decrease in cell 
proliferation when compared to normoxia. This indicates 
that pH 6.5 significantly affects cell viability (Fig. 2A). We 
also found that changes in pH do not affect the number of 
apoptotic cells at 24, 48 and 72 h when compared to normoxia 
(Fig. 2B).
Next, we determined cell viability in the pH+chemical 
hypoxia model. We found no changes at any of the three 
pH values analyzed (Fig. 2C). Finally, we observed that the 
pH+sealed chamber hypoxia model promotes an increase in 
viability at pH 6.9 and 6.7 when compared to normoxia at 
48 h (Fig. 2D). After 72 h, we still found an increase in cell 
viability at pH 6.7 and no changes at pH 6.9 and 6.5 (Fig. 2D). 
These results reproduce, at least in part; those observed in the 
independent measurements of hypoxia or acidity and support 
the effect of pH on cell viability during hypoxia.
Table I. Primer sequence used in the quantification of the 
expression of genes sensible to stress.
A, Hypoxia sensitive genes
Gene Sequence
HIF1α
  F ATCCATGTGACCATGAGGAAATG
  R TCGGCTAGTTAGGGTACACTTC
EPO
  F GGAGGCCGAGAATATCACGAC
  R CCCTGCCAGACTTCTACGG
CA9
  F GGATCTACCTACTGTTGAGGCT
  R CATAGCGCCAATGACTCTGGT
VEGF
  F AGGGCAGAATCATCACGAAGT
  R AGGGTCTCGATTGGATGGCA
GLUT1
  F TCTGGCATCAACGCTGTCTTC




  F ACAACTTTGGTATCGTGGAAGG
  R GCCATCACGCCACAGTTTC
GLUT1, glucose transporter 1; VEGF, vascular endothelial growth 
factor; HIF1α, hypoxia-inducible factor 1A; EPO, erythropoietin.
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Effect of pH on the expression of hypoxia response genes. To 
implement the standardization of the hypoxia model, we initially 
evaluated the effect of pH on six genes related to hypoxia 
response: HIF1α, EPO, VEGF, GLUT1, CA9, and LDH. These 
results suggest that pH changes are not involved as genetic modu-
lators of HIF1α, EPO, VEGF, GLUT1, CA9, and LDH (Fig. 3).
Gene expression comparison in the two models of hypoxia. We 
evaluated the expression of the same six genes in two hypoxia 
models. When we compared the two models we observed that 
the hypoxia induced by CoCl2 promotes an acute time specific 
increase in gene expression at 6 h and later showed a decrease 
to control values (Fig. 4). Observations of the hypoxia-induced 
sealed gas chamber show a stable effect on gene expression 
displaying a lower, gradual and maintained elevation. At 72 h, 
the effect is maintained and HIF1α, EPO, and CA9 are still 
overexpressed. Finally, the gene GLUT1 stands out in that it only 
maintains basal levels of expression in both models (Fig. 4). At 
Figure 1. Cell viability and apoptosis under both models of hypoxia. (A) Chemical model and (B) Gas chamber. It is observed that in the (Α) chemical model 
there is cell death starting at 48 h while in the (Β) gas chamber model there is an increase in cell viability, compared to the control. There is the same cell 
death (apoptosis) in the (C) chemical model with respect to the normal control (statistical significance *P<0.01), while the contrary occurred in the (D) cells 
maintained in the gas chamber at 72 h.
Figure 2. Acidity effect on cell viability. Cell viability was measured at different pH: 6.5, 6.7 and 6.9 in (A) standard (normoxia) culture conditions, (B) in 
chemically induced hypoxia, and (C) by gas chamber. (A) In normoxia conditions and (B) chemical model induced cell viability and behavior in cell viability 
has a pattern similar to the increase in plate confluence. (C) In the hypoxia induced by chamber an increase in viability at 48 or 72 h with pH 6.7 was observed. 
Apoptosis induction (D) in the Caco‑2 cell line in normoxia conditions at acid pH increases with time but is independent of pH concentration (statistical signifi-
cance *P<0.01). 6.9-Hco, Hypoxia chemically induced with pH 6.9; 6.7-Hco, hypoxia chemically induced whit pH 6.7; 6.5-Hco, hypoxia chemically induced 
with pH 6.5; 6.9-Hca, hypoxia-induced in gas chamber with pH 6.9; 6.7-Hca, hypoxia-induced in gas chamber whit pH 6.7 and 6.5-Hca, hypoxia-induced in 
gas chamber with pH 6.5.
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Figure 3. pH effect on the expression of six genes. Expression of HIF1α, EPO, VEGF, GLUT1, CA9 and LDH in Caco-2 cells at different induction of pH 
measured by qPCR. Expression levels are normalized to expression of the housekeeping gene GAPDH.
Figure 4. Expression of six genes in two hypoxia models. Expression of (A) HIF1α, (B) EPO, (C) VEGF, (D) GLUT1, (E) CA9 and (F) LDH in Caco-2 cells at 
different induction of hypoxia measured by qPCR. Expression levels are normalized to expression of the housekeeping gene GAPDH. Hco, hypoxia chemically 
induced; Hca, hypoxia-induced in gas chamber.
CALVO-ANGUIANO et al:  COMPARISON OF SPECIFIC EXPRESSION PROFILE IN TWO in vitro HYPOXIA MODELS4782
this stage, our results suggest that chemical hypoxia modulates 
gene expression profile at 6 h whereas hypoxia-dependent 
chamber leads its major effects at 72 h.
Finally, we found an early increase in HIF1α expression 
that peaked at 6 h following a decrease later on (Fig. 4A). At 
6 h, we also identified an increase of EPO, VEGF, GLUT1 and 
LDH genes (Fig. 4B‑D and F). No significant changes were 
found in CA9 (Fig. 4E).
Global gene expression profile in the two hypoxia models 
using microarrays. We used microarray analysis to deter-
mine the effect of global gene expression in the two hypoxia 
models: Chemical (6 h) and sealed chamber (72 h) induced 
hypoxia. We identified a gene expression profile for each 
model (Fig. 5A and B). The chemical hypoxia model promotes 
downregulation of 3 genes (CYP1A1, CYP1B1, and CYCS) and 
the overexpression of 27 genes: TXNIP, ALDH1L2, FAM169A, 
ZBTB20, RORA, CREBRF, FBXL20, LOX, ZNF846, YPEL2, 
PPM1A, FAM225A, NGFR, VLDLR‑AS1, MT1M, ANKRD37, 
SPAG4, BNIP3L, ATP8B2, AKR1C1, SLC7A11, AQP10, 
AKR1C1, KLHL24, DDIT4, PCK1, JMY. For the sealed gas 
chamber model, we found the subexpression of 2 genes: UTS2 
and MMP1 and the overexpression of 28 genes: LINC01293, 
CASP5, RORA, SLC6A8, ZG16, GNRH2, CREBRF, 
FAM129A, ANKRD37, CLIC3, ENO2, PCAT6, BHLHE40, 
BNIP3L, TMEM45A, TMEM27, DDIT4, FRMD3, CXCR4, 
NRN1, ATP8B2, SPAG4, LGALS14, AQP10, LOX, BNIP3, 
PDK1, NDRG1. We also observed that nine genes were shared 
between both models (SPAG4, LOX, BNIP3L, ATP8B2, 
AQP10, RORA, DDIT4, CREBRF, and ANKRD37) (Fig. 5C).
On the other hand, we compared the gene signatures obtained 
from both models with the report of Sørensen et al (19) that 
reported a signature of 15 genes sensitive to hypoxia, finding 
3 common genes in all the genetic signatures, suggesting that 
our data correlates with a universal genetic signature for the 
hypoxia profile (Fig. 6).
Figure 5. Gene expression levels in normoxic and hypoxic cells. (A and B) Heatmap of the genes from the hypoxia profile in both models. The color bar shows 
the fold change relative to the median expression of each gene across all conditions. The data shows the mean value of two independent experiments, and 
are log2 transformed. (C) Venn Diagram shows genes from hypoxia profile in both models with the deregulated genes obtained in microarray expression. 
Left: Signature hypoxia chamber shows 21 deregulated genes. Right: Signature hypoxia CoCl2 shows 21 deregulated genes. Intersection: Nine genes shared 
in both models.
Figure 6. Deregulated genes. Venn diagram with the deregulated genes 
obtained in microarray expression. Left: Signature hypoxia chamber shows 
30 deregulated genes. Right: Signature hypoxia CoCl2 shows 30 deregu-
lated genes. Center: Signature Sorensen 2015 shows 15 deregulated genes. 
Intersection: Three genes, which are shared in three signatures.
EXPERIMENTAL AND THERAPEUTIC MEDICINE  15:  4777-4784,  2018 4783
Discussion
Experimental evidence has shown the effect of hypoxia induc-
tion in vitro using the technical strategies implemented in our 
study (20-23). In general terms, one of the best candidates to 
identify the hypoxia model is the evaluation of HIF1α expres-
sion. However, additional potential candidates are emerging to 
validate sensor genes in hypoxia and its metabolic effect, but 
they are not yet validated (13,24,25). In this study, we evaluated 
five target genes of HIF1α along with parameters of viability 
and apoptosis in two models of hypoxia, widely cited in the 
literature and with the potential to be interchangeable. We 
found that both models show similarities in the final induction 
of hypoxia and show no significant differences. However, we 
identified selective time‑dependent changes particularly related 
to the induction of HIF1α as a response to hypoxia. In addi-
tion, when the expression of the rest of the genes is analyzed, a 
variable expression is observed in the different times evaluated. 
For example, at 6 h in the CoCl2 model, we found the highest 
expression of all the genes evaluated, followed by a low expres-
sion and tendency to reach normal values in later times, such 
as 48 and 72 h. In contrast, the gas chamber model showed 
increased and gradual gene expression, which was maintained 
for up to 72 h. This indicates that in the chemical model, the 
cells normalize the system rapidly at 3 to 6 h and in the hypoxia 
CoCl2 model the effect is rapidly reversed. On the other hand, in 
the gas chamber model, the cells slowly adapted to the change 
in a time-dependent manner and the effect was observed and 
maintained in response to hypoxia.
We propose that these observations must be considered 
when choosing one of this hypoxia models in order to define if 
the effect that is desired to quantify is analyzed from 3 to 6 h 
or even a more prolonged time, as was proposed recently (26).
One of the major achievements of our study is that we show, 
for the first time, a comparison in both chemical and chamber 
hypoxia models in different scenarios and identify a selective 
expression of the genes induced by HIF1α. Our results also 
show that the effect of hypoxia induction is time sensitive and 
selective for each model. For example, a study reported by 
Danli Wu in 2011 using both hypoxia models quantifies HIF1α 
as the only hypoxia marker in this scenario (16).
Potentials pathways mainly affected by hypoxia are 
glycolysis and oxidative phosphorylation (27). In this scenario 
cell viability assays may have technical limitations when the 
main goal is to quantify cell viability (28-30). For instance, no 
changes in oxidative phosphorylation and cellular ATP levels 
have been reported in in vitro trials trying to simulate condi-
tions of lack of nutrients and hypoxia models (28-30). In our 
project we determined cell viability by using ATP quantifica-
tion as a reliable marker of cell viability. However, we also 
agree that ATP levels can be altered by hypoxic conditions and 
this measurement might not be an indicator of cell viability so 
metabolic activity marker in cells.
Despite that our two hypoxia models show a selective 
time leading to HIF1α upregulation, we found 9 common 
hypoxia-inducible genes between both models, as observed in 
the Venn diagram (Fig. 5C). Our data correlate with previous 
results showing that hypoxia regulates similar metabolic path-
ways such as: Glycolysis, pyruvate metabolism, ATP synthesis, 
regulation of processes (catalytic activity, hydrolases, oxido-
reductases) and other cellular processes like adhesion or 
transport (Fig. 7) (23,24). In particular, Sørensen et al (19) 
in 2015 reported a 15 hypoxia-regulated genes signature 
as a universal hypoxia profile in various cancer cell types. 
Our data correlate with the LOX, ANKRD37, BNIP3L genes 
(Fig. 6), previously reported by Sørensen et al (19). This 
Figure 7. Genes regulated by hypoxia. Genes that are regulated by hypoxia and acidity in our work. The first line shows genes previously described. In blue: 
Genes traditionally referred to as genes of response to hypoxia; in red: A group of genes that have recently been considered as new hypoxia response genes; in 
the second line: Gas chamber model; and in the third line: Chemical model, we describe genes that were identified in this work and have not been previously 
reported.
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indicates that these three genes are highly regulated by the 
effect of hypoxia regardless of the hypoxia model induced 
with. At this stage, we propose that LOX, ANKRD37, BNIP3L 
genes might potentially be added as universal hypoxia genes 
along with HIF1α, EPO, VEGF, GLUT1, CA9 and LDH previ-
ously characterized.
In summary, in this study, we show that the effect of 
hypoxia is time-dependent regarding the hypoxia model 
used. Chemical induction simulates an acute hypoxia whereas 
chamber of gases maintains the effect of hypoxia in extended 
periods. These two hypoxia models share 9 susceptible 
genes and when comparing the two models of hypoxia with 
that reported by Sørensen et al (19), we found 3 genes (LOX, 
ANKRD37, BNIP3L) that could be considered as universal 
hypoxia genes along with HIF1α, EPO, VEGF, GLUT1, CA9, 
and LDH.
Our study opens a new research area showing the signifi-
cant value of identifying potential oxygen sensors and key 
genes involved in metabolism and stress conditions during 
hypoxia. Finally, it might be required to study the expression 
and methylation of these genes to amplify the knowledge in 
this area and to better evaluate the effect of hypoxia in the 
mechanisms of cancer progression and metabolism of tumor 
cells.
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